Association of Serum Phosphorus Levels With QT Prolongation in Patients With End‐Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients
Therapeutic Apheresis and Dialysis · 2026-12 · 30 (6) · 943-949
DOI: 10.1002/1744-9987.70184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 07.07.2026. Verfasst von Sho Sasaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Innovative Research for Communities and Clinical Excellence (CiRC2LE), Fukushima Medical University, Fukushima, Japan. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Kidney Failure, Chronic, Phosphorus, Long QT Syndrome. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Serum phosphorus (P) levels have been associated with QT interval prolongation in patients undergoing hemodialysis. However, it is unclear whether this association exists in patients undergoing peritoneal dialysis (PD) in the absence of acute electrolyte fluctuations.
Methods
This cross‐sectional study was conducted among adult patients on maintenance PD who were enrolled in the Japanese Society for Dialysis Therapy and Renal Data Registry in 2020. After assessing patient characteristics, a linear regression analysis was performed with serum calcium (Ca) and P levels as exposures and rate‐corrected QT (QTc) interval as the outcome.
Results
This study included 3566 patients with a mean QTc of 449.1 ± 34.5. Of these, 251 (7.0%) had QT interval prolongation (QTc > 500 msec). Univariate analysis showed a statistically significant association between lower corrected Ca and longer QTc interval, as well as higher P and longer QTc. Only the association between higher P and longer QTc remained statistically significant in multivariate analysis. Restricted cubic spline showed that QTc tended to increase with lower corrected Ca, whereas QTc time tended to increase with higher phosphate levels.
Conclusion
An association between hypocalcemia and QT interval prolongation was confirmed in patients undergoing PD, similar to findings in hemodialysis. However, unlike in hemodialysis, an association between serum P levels and QT interval was found only in cases of hyperphosphatemia and not in the context of hypophosphatemia and QT interval prolongation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Innovative Research for Communities and Clinical Excellence (CiRC2LE), Fukushima Medical University, Fukushima, Japan.
- Department of General Medicine, Iwase Satellite for Teaching and Research (STAR), Fukushima Medical University, Fukushima, Japan.
- Section of Clinical Epidemiology, Department of Community Medicine, Kyoto University, Kyoto, Japan.
- Department of Nephrology, Iizuka Hospital, Fukuoka, Japan.
- Division of Nephrology, Toho University Ohashi Medical Center, Tokyo, Japan.
- Tojinkai Hospital, Kyoto, Japan.
ORCID-Profile: Sho Sasaki, Kiichiro Fujisaki, Norio Hanafusa, Nobuhiko Joki
Zitieren
APA
Sasaki, S., Fujisaki, K., Uematsu, H., Nishimura, M., Nakano, T., Abe, M., Hanafusa, N., & Joki, N. (2026). Association of Serum Phosphorus Levels With QT Prolongation in Patients With End‐Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients. Therapeutic Apheresis and Dialysis, 30(6), 943-949. https://doi.org/10.1002/1744-9987.70184
Vancouver
Sasaki S, Fujisaki K, Uematsu H, Nishimura M, Nakano T, Abe M, et al. Association of Serum Phosphorus Levels With QT Prolongation in Patients With End‐Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients. Therapeutic Apheresis and Dialysis. 2026;30(6):943-949. doi:10.1002/1744-9987.70184
BibTeX
@article{Sasaki2026,
author = {Sasaki, Sho and Fujisaki, Kiichiro and Uematsu, Hikaru and Nishimura, Masato and Nakano, Toshiaki and Abe, Masanori and Hanafusa, Norio and Joki, Nobuhiko},
title = {Association of Serum Phosphorus Levels With QT Prolongation in Patients With End‐Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
volume = {30},
number = {6},
pages = {943--949},
doi = {10.1002/1744-9987.70184}
}
EUVIMED